Neurocrine Biosciences, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US64125C1099
USD
154.22
1.74 (1.14%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
2,355.30
1,887.10
1,488.70
1,133.50
1,045.90
788.09
451.24
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,355.30
1,887.10
1,488.70
1,133.50
1,045.90
788.09
451.24
Raw Material Cost
57.50
57.50
38.30
25.20
18.70
14.88
4.89
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
126.60
4.60
7.10
25.80
32.80
31.96
30.53
Selling and Distribution Expenses
993.20
887.60
751.00
583.30
433.30
354.06
248.93
Other Expenses
58.10
54.26
44.16
29.14
23.36
16.06
13.00
Total Expenditure (Excl Depreciation)
1,758.30
1,492.30
1,238.00
925.70
718.40
561.53
414.35
Operating Profit (PBDIT) excl Other Income
597
394.79999999999995
250.7
207.8
327.5
226.6
36.9
Other Income
91.00
57.40
11.20
3.80
12.60
19.21
15.48
Operating Profit (PBDIT)
715.10
473.50
277.50
222.50
348.70
253.22
56.40
Interest
126.60
4.60
7.10
25.80
32.80
31.96
30.53
Exceptional Items
-75.40
-115.50
-40.90
-84.40
-200.60
-167.26
0.00
Gross Profit (PBDT)
2,297.80
1,829.60
1,450.40
1,108.30
1,027.20
773.21
446.35
Depreciation
27.10
21.30
15.60
10.90
8.60
7.45
4.02
Profit Before Tax
486.00
332.10
213.90
101.40
106.70
46.54
21.84
Tax
144.70
82.40
59.40
11.80
-300.60
9.53
0.73
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
341.30
249.70
154.50
89.60
407.30
37.01
21.11
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
341.30
249.70
154.50
89.60
407.30
37.01
21.11
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
341.30
249.70
154.50
89.60
407.30
37.01
21.11
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
2,589.70
2,232.00
1,707.80
1,374.00
1,126.20
636.92
480.76
Earnings per share (EPS)
3.29
2.47
1.56
0.92
4.16
0.39
0.22
Diluted Earnings per share
3.29
2.47
1.56
0.92
4.16
0.39
0.22
Operating Profit Margin (Excl OI)
25.35%
20.92%
16.84%
18.33%
31.31%
28.75%
8.18%
Gross Profit Margin
21.78%
18.73%
15.42%
9.91%
11.02%
6.85%
5.73%
PAT Margin
14.49%
13.23%
10.38%
7.9%
38.94%
4.7%
4.68%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 24.81% vs 26.76% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 36.68% vs 61.62% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 49.99% vs 56.25% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 2,652.17% vs -35.21% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Neurocrine Biosciences, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
2,355.30
1,901.98
453.32
23.83%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,355.30
1,901.98
453.32
23.83%
Raw Material Cost
57.50
356.82
-299.32
-83.89%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
238.33
-238.33
-100.00%
Power Cost
0
0
0.00
Manufacturing Expenses
126.60
18.39
108.21
588.42%
Selling and Distribution Expenses
993.20
548.60
444.60
81.04%
Other Expenses
58.10
52.18
5.92
11.35%
Total Expenditure (Excl Depreciation)
1,758.30
1,683.90
74.40
4.42%
Operating Profit (PBDIT) excl Other Income
597.00
218.08
378.92
173.75%
Other Income
91.00
68.92
22.08
32.04%
Operating Profit (PBDIT)
715.10
340.89
374.21
109.77%
Interest
126.60
18.39
108.21
588.42%
Exceptional Items
-75.40
-7.84
-67.56
-861.73%
Gross Profit (PBDT)
2,297.80
1,545.16
752.64
48.71%
Depreciation
27.10
53.89
-26.79
-49.71%
Profit Before Tax
486.00
260.77
225.23
86.37%
Tax
144.70
25.54
119.16
466.56%
Provisions and contingencies
0
0
0.00
Profit After Tax
341.30
235.24
106.06
45.09%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
341.30
235.24
106.06
45.09%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
341.30
235.24
106.06
45.09%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
2,589.70
1,527.74
1,061.96
69.51%
Earnings per share (EPS)
3.29
2.34
0.95
40.60%
Diluted Earnings per share
3.29
2.34
0.95
40.60%
Operating Profit Margin (Excl OI)
25.35%
11.47%
0.00
13.88%
Gross Profit Margin
21.78%
16.54%
0.00
5.24%
PAT Margin
14.49%
12.37%
0.00
2.12%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 235.53 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 24.81% vs 26.76% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 34.13 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 36.68% vs 61.62% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 62.41 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 49.99% vs 56.25% in Dec 2023

Annual - Interest
Interest 12.66 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 2,652.17% vs -35.21% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 25.35%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023